Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | -1.59% | -10.18% | -12.10% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmacology Services
94.1
%
| 47 | 95.4 % | 51 | 94.1 % | +8.27% |
Other Translational Oncology Solutions
5.7
%
| 2 | 4.5 % | 3 | 5.7 % | +36.78% |
Personalized Oncology Services
0.2
%
| 0 | 0.1 % | 0 | 0.2 % | +136.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 49 | 100.0 % | 54 | 100.0 % | +9.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
David Miller
DFI | Director of Finance/CFO | 55 | 13-05-31 |
Karin Heidemann
CTO | Chief Tech/Sci/R&D Officer | - | 19-08-31 |
Maria Mancini
COO | Chief Operating Officer | - | 15-02-28 |
Philip Breitfeld
BRD | Director/Board Member | 71 | 16-04-10 |
Rachel Bunting
IRO | Public Communications Contact | - | - |
Marianna Zipeto
PRN | Corporate Officer/Principal | - | 20-02-29 |
Ido Ben-Zvi
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Daniel Mendelson
BRD | Director/Board Member | 60 | 13-02-28 |
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Philip Breitfeld
BRD | Director/Board Member | 71 | 16-04-10 |
Robert Brainin
BRD | Director/Board Member | 53 | 21-02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,714,099 | 10,119,930 ( 73.79 %) | 120,333 ( 0.8774 %) | 73.79 % |
Company contact information
Champions Oncology, Inc.
One University Plaza Suite 307
07601, Hackensack
+201 808 8400
http://www.championsoncology.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-12.10% | 67.15M | |
+9.19% | 45.97B | |
+52.95% | 43.93B | |
+8.47% | 42.34B | |
-8.59% | 28.27B | |
+17.98% | 27.18B | |
-20.88% | 19.44B | |
+14.50% | 13.83B | |
+31.67% | 12.4B | |
+9.73% | 11.45B |
- Stock
- Equities
- Stock Champions Oncology, Inc. - Nasdaq
- Company Champions Oncology, Inc.